Sysmex Corporation

Equities

6869

JP3351100007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,488 ^JPY	-0.02%		+7.13%	-5.03%

Feb. 13	Sysmex to Carry Out 3-for-1 Stock Split; Shares Jump 4%	MT
Feb. 09	Sysmex Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	CI

Sysmex Corporation acquired additional unknown stake in Megakaryon Corporation.

December 20, 2023

Sysmex Corporation (TSE:6869) acquired additional unknown stake in Megakaryon Corporation on December 20, 2023. After completion, Sysmex now holds 80.9% stake in Megakaryon Corporation.

Sysmex Corporation (TSE:6869) completed the acquisition of additional unknown stake in Megakaryon Corporation on December 20, 2023.

Latest news about Sysmex Corporation

Sysmex to Carry Out 3-for-1 Stock Split; Shares Jump 4%	Feb. 12	MT
Sysmex Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	Feb. 09	CI
Sysmex Corporation Reaffirm Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 09	CI
Cellavision, Sysmex Expand Hematology Partnership Deal	Feb. 06	MT
CellaVision and Sysmex Corporation Sign Strategic Alliance Agreement	Feb. 06	CI
Germany’s USU Software Signs Knowledge Management Deal with Japan’s Sysmex	Jan. 16	MT
Jefferies Adjusts Sysmex’s Price Target to 8,500 Yen From 8,800 Yen, Keeps at Hold	Jan. 04	MT
Sysmex Corporation acquired additional unknown stake in Megakaryon Corporation.	Dec. 20	CI
Fujirebio Holdings, Inc. and Sysmex Corporation Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay	Dec. 14	CI
VCCT Inc announced that it has received ¥600 million in funding from YASKAWA Electric Corporation, Dai-Dan Co., Ltd., Sysmex Corporation	Nov. 14	CI
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary	Nov. 03	MT
New entries in MarketScreener's Asia portfolio	23-10-24
Fujirebio Holdings, Inc. and Sysmex Corporation Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay	23-10-10	CI
Dpa-AFX Overview: COMPANIES of 03.08.2023 - 15.15 o'clock	23-08-03	DP
Sysmex Corporation Announces Management Changes	23-02-07	CI
Jefferies Adjusts Sysmex’s Price Target to 8,200 Yen From 7,300 Yen, Keeps at Hold	23-01-16	MT
Sysmex America, Inc. Appoints Chris Cappella as Chief Financial Officer	23-01-10	CI
High Inflation Makes Japanese Stocks Bleed Losses; Toshiba Rises 2% as Bidder Moves Closer to Securing Buyout Funding	22-12-23	MT
Sysmex says Japan approves blood test for Alzheimer's marker	22-12-22	RE
Japan Index Witnesses Strong Buying; Shares of Sysmex, JCR Pharmaceuticals Expand 4% on Regenerative Medicine JV	22-10-04	MT
Shares of JCR Pharmaceuticals, Sysmex Expand 4% on Regenerative Medicine JV	22-10-04	MT
Jcr Pharmaceuticals Co., Ltd. and Sysmex Establish A Joint Venture in the Field of Regenerative Medicine and Cell Therapy	22-10-03	CI
New entries in the Asia Investor portfolio	22-07-27
UBS Adjusts Sysmex's Price Target to 11,300 Yen From 12,500 Yen, Keeps at Buy	22-06-06	MT
Sysmex Shares Jump After Fiscal-Year Net Profit Rose 38%	22-05-12	DJ

Chart Sysmex Corporation

Duration

Period

More charts

Company Profile

Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Sysmex Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2,488 JPY

Average target price

3,050 JPY

Spread / Average Target

+22.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SYSMEX CORPORATION	-5.03%	9.85B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution